Patient leaflet - Teslascan
2. BEFORE YOU USE T
Do not use TESLASCAN if one of the following conditions exists:
Pregnancy Allergy ( Pheochro Breast-fe Severe kidney disease er disease
vity) to the active substance or any of the other ingredients of TESLASCAN
ecial care with TESLASCAN if one of the following conditions exists:
Severe heart disease – in particular heart failure or when there is a risk of disorders of heart rhythm in patients with injuries of the blood brain barrier and severe cerebral disease
Rarely, hypersensitivity reactions (urticaria and other possible allergic phenomena) may occur.
Using other medicines:
Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Pregnancy and breast-feeding
TESLASCAN must not be used if you are pregnant.
The amount of TESLASCAN in breast milk is not known. As a precaution, to prevent exposing infants to the medicine, breast-feeding should be stopped from the time of dosing and all milk should be discarded for the first 14 days afterwards.
Driving and using machines:
y weight is the
No effects are known. There is no reason why you cannot drive after the investigation, unless you fe dizzy or are unsure of yourself.
Important information about some of the ingredients of Teslascan
This medicine contains 5.5 mmol (126 mg) sodium per normal dose of 35 ml. To be consideration by patients on a controlled sodium diet.
3. HOW TO USE TESLASCAN
TESLASCAN is for use in patients over the age of 18 years.
Dosage:
The amount given will depend on the weight of the recommended dosage for adults and elderly.
TESLASCAN is for intravenous use and will be infused before the MRI examination. TESLASCAN may be infused into a vein, normally an arm vein, via a thin plastic tube. The administration may last for up to 15–20 minutes.
TESLASCAN should be visually insper particulate matter and for the integrity of the container prior to use. Vials are intended for single use only. The medicinal product should not be mixed with other medicinal products. Any unused portions must be discarded.
There is no known the hospital.
Overdose
High doses induce dist
his contrast medium. Treatment of any overdose will be performed at ill be supportive to relieve the symptoms.
anese can make the heart pump less efficiently, dilate the blood vessels, as well as s of heart rhythm.
OSSIBLE SIDE EFFECTS
l medicines, TESLASCAN can cause side effects, although not everybody gets them.
The reported side effects are usually mild and of short duration:
Common (1 in 100 to 1 in 10 patients experiences the side effect):
- Headache
- Nausea
- Feeling of warmth/flushing
Uncommon (1 in 1,000 to 1 in 100 patients experiences the side effect):
- Hypersensitivity reactions (e.g., skin reactions, rhinitis (nasal catarrh) pharyngitis (throat inflammation))
- Fever
- Diarrhoea
- Vomiting
- Dizziness
- Palpitation
- Paraesthesia (sensation of tingling)
- Abdominal pain
- Injection site pain
- Taste sensations
Anaphylactoid reactions (wheeziness, difficulty in breathing or tightness or pain in the chest) may occur.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell the radiologist/radiographer or your doctor or pharmacist.
5. HOW TO STORE TESLASCAN
Keep out of the reach and sight of children.
Expiry date
Do not use TESLASCAN after the expiry date which is stated on the label after EXP. The expiry date refers to the last day of that month.
Storage precautions
Keep the vial in the outer carton in order to protect from light.
Once opened the product should be used immediately. For single use only. Any unused portion should be discarded.
Do not use Teslascan if the colour changes from dark yellow to brown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
-
6. FURTHER INFORMATION
What TESLASCAN contains
-
- The active substance is mangafodipir trisodium.
What TESLASCAN looks like and contents of the pack
Solution for infusion.The solution is clear and bright to dark yellow in colour.
The medicine is supplied in pack of:
1 vial of 50 ml
10 vials of 50 ml
Not all pack sizes may be marketed
Marketing Authorization Holder and Manufacturer:
GE Healthcare AS
Nycoveien 1–2
P.O. Box 4220 Nydalen
NO-0401 OSLO, Norway
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder.
België/Belgique/Belgien
GE Healthcare BVBA Kouterveldstraat 20
BE-1831 Diegem Tél/Tel: + 32 (0) 2
Luxembourg/Luxemburg GE Healthcare BVBA
Kouterveldstraat 20
BE-1831 Diegem België/Belgique/Belgien
Tél/Tel: + 32 (0) 2 719 74 01
Efcnrapua
GE Healthcare SCE Handels GmbH Reptative Office Bulgaria Woade Centre, Office 405–406 6yn. ^paraH U,aHKOB 36
Co^ua 1040
Ten.: + 35 92 973 3170
Magyarorszag
GE Healthcare SCE Handels GmbH Hungary Representative Office Akron u.2.
H-2040 BUDAORS
Tel. + 36 23 410 410
Česká republika
GE Healthcare SCE Handels GmbH
Branch Office Czech Republic
Vyskočilova 1422/1a
CZ-140 28 Praha 4
Malta
Pharma-Cos Ltd
Triq C. Portanier MT-Santa Venera HMR 11 Tel: +356 21 441870
Tel: + 420 224 446 179
Danmark
GE Healthcare A/S
Huginsvej 8
DK-3400 Hillerod
Tlf: + 45 70 22 22 03
Deutschland
GE Healthcare Buchler GmbH & Co. KG
Gieselweg 1
D-38110 Braunschweig
Tel: + 49 5307 9300
Eesti
GE Healthcare Estonia OÜ
Mustamäe tee 46
EE – 10621 Tallinn
Tel: + 372 6260 061
EÀÀàôa
GE Healthcare A.E.
nXanoÛTa 139 & Aapiaç GR – 141 21 N. HPAKAEIO A0HNA
Tql: +30 210 805 08 64
Nederland
GE Healthcare BV Cygne Centre
De Rondom 8
NL-5612 AP Eindhoven Tel: + 31 40 299 10 00
Polska
GE Healthcare Poland Represe 2 Stawki Str.
Norge
GE Healthcare AS
Nycoveien 1–2
NO-0401 Oslo
Tlf: + 47 23 18 50 50
Österreich
GE Healthcare Handels GmbH
Europlaza, Gebäude E
Technologiestrasse 10
A-1120 Wien
Tel: + 43 1 972 72–0
PL – 00
Tel.: + 4
els GmbH Office
arszawa
635 6886/6113
España
GE Healthcare Bio-Sciences, S.A.
Avda. de Europa, 22
Parque Empresarial ”La Moraleja”
E-28108 Alcobendas, Madrid
France
GE Healthcare SA
11, avenue Morane Saulni
F-78 140 Velizy Vi
Tél: + 33 1 34 49 5
Ireland
GE Hea Amersh Little C
Tel: + 34 91 663 25 00 lthcare Limited
am Place
halfont HP7 9NA – UK
4 (0) 1 494 54 4000
and
arm ehf.
Lyngháls 13
IS-110 Reykjavik
Sími: +354 540 8024
Portugal
Satis Lda.
Av. Do Forte, No 4
P-2795–502 Carnaxide
Tel: + 351 214 25 1300
Romania
GE Healthcare SCE Handels GmbH
Representative Office Romania
Str. Navodari Nr. 42
Sc.2, et.2
RO-014108 BUCHAREST
Tel: + 40 21 23 211 53
Slovenija
HIGIEA d.o.o.
Blatnica 10
SI-1236 Trzin
Tel: + 386 1 589 7221
Slovenská republika
GE Healthcare SCE Handels GmbH
Branch Office Slovakia
Floriánske nám. 2
SK-811 07 Bratislava
Tel: + 421 2 5542 5948
Italia GE Healthcare Srl Via Galeno 36 I-20126 Milano Tel: + 39 02 26001 111 Kvnpog Phadisco Ltd Aeopopog ftavvou Kpaviöirnin 185 CY-2235 AaTGia Tql: +357 22 715000 Latvija Instrumentarium Medical SiA Meza Str. 4 LV-1048 Riga Tel: + 371 780 7086 Lietuva Nycomed East Europe Marketing Service GmbH Seimyniskiu 3 LT – 09312 Vilnius Tel. +370 5210 9071 This leaflet was last approved in | Suomi/Finland Oy GE Healthcare Bio-Sciences Ab Kuortaneenkatu 2 FIN-00510 Helsinki Puh/Tel: + 35 810 394 11 Sverige GE Healthcare AB Solna Strandväg 98 S-171 75 Stockholm Tel: + 46 8 559 504 00 United Kingdom GE Healthcare Limited Amersham Place Little Chalfont HP7 9NA – UK Tel: + 44 (0) 1 494 54 4000 \O |
22